Citadel Advisors
MOR

Citadel Advisors’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Citadel Advisors’s Portfolio MOR Stock Details MOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,594
Closed -$65.3K – 15728
2024
Q1 		$65.2K Sell
3,594
-94,604
-96% -$1.4M ﹤0.01% 11903
2023
Q4 		$972K Sell
98,198
-35,082
-26% -$258K ﹤0.01% 6746
2023
Q3 		$896K Buy
133,280
+98,847
+287% +$761K ﹤0.01% 6813
2023
Q2 		$257K Buy
+34,433
New +$210K ﹤0.01% 9351
2022
Q4 		– Sell
-20,049
Closed -$101K – 15607
2022
Q3 		$101K Buy
+20,049
New +$104K ﹤0.01% 11087
2022
Q1 		– Sell
-50,807
Closed -$479K – 14822
2021
Q4 		$479K Buy
+50,807
New +$539K ﹤0.01% 9800
2021
Q1 		– Sell
-33,883
Closed -$960K – 13841
2020
Q4 		$960K Sell
33,883
-71,808
-68% -$1.97M ﹤0.01% 6881
2020
Q3 		$3.32M Sell
105,691
-11,367
-10% -$368K ﹤0.01% 3815
2020
Q2 		$3.71M Buy
117,058
+86,653
+285% +$2.53M ﹤0.01% 3519
2020
Q1 		$747K Buy
30,405
+7,308
+32% +$215K ﹤0.01% 5819
2019
Q4 		$824K Buy
23,097
+5,362
+30% +$160K ﹤0.01% 5950
2019
Q3 		$487K Sell
17,735
-484
-3% -$13.9K ﹤0.01% 6800
2019
Q2 		$440K Buy
18,219
+2,728
+18% +$67.6K ﹤0.01% 7012
2019
Q1 		$352K Sell
15,491
-4,808
-24% -$126K ﹤0.01% 7376
2018
Q4 		$512K Buy
+20,299
New +$533K ﹤0.01% 6353
2018
Q3 		– Sell
-80,505
Closed -$2.44M – 9815
2018
Q2 		$2.44M Buy
+80,505
New +$2.21M ﹤0.01% 3792

Other funds holding MOR

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citadel Advisors's MOR Position: Q2 2024 in Review

Citadel Advisors sold out of MorphoSys AG American Depositary Shares (MOR) in Q2 2024, closing a stake of 3,594 shares — an estimated $65.3K sold.

Citadel Advisors first reported a position in MOR in Q2 2018 and held it in 16 quarters. The position peaked at $3.71M in Q2 2020. 26 funds tracked by Wall St. Rank hold MOR as of Q2 2024.

  • Citadel Advisors reported no remaining MorphoSys AG American Depositary Shares position as of Q2 2024 after selling out during the quarter.
  • Citadel Advisors sold 3,594 MorphoSys AG American Depositary Shares shares in Q2 2024, an estimated $65.3K.
  • Citadel Advisors first reported a position in MorphoSys AG American Depositary Shares in Q2 2018 and held it in 16 quarters.
  • Citadel Advisors's MorphoSys AG American Depositary Shares position peaked at $3.71M in Q2 2020.
  • 26 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q2 2024.

Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.